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PARylation [poly(ADP-ribosyl)ation] is involved in the
maintenance of genomic methylation patterns through its control
of Dnmt1 [DNA (cytosine-5)-methyltransferase 1] activity. Our
previous findings indicated that Ctcf (CCCTC-binding factor)
may be an important player in key events whereby PARylation
controls the unmethylated status of some CpG-rich regions. Ctcf
is able to activate Parp1 [poly(ADP-ribose) polymerase 1], which
ADP-ribosylates itself and, in turn, inhibits DNA methylation via
non-covalent interaction between its ADP-ribose polymers and
Dnmt1. By such a mechanism, Ctcf may preserve the epigenetic
pattern at promoters of important housekeeping genes. The results
of the present study showed Dnmt1 as a new protein partner
of Ctcf. Moreover, we show that Ctcf forms a complex with
Dnmt1 and PARylated Parp1 at specific Ctcf target sequences
and that PARylation is responsible for the maintenance of the
unmethylated status of some Ctcf-bound CpGs. We suggest a
mechanism by which Parp1, tethered and activated at specific
DNA target sites by Ctcf, preserves their methylation-free status.
Key words: CCCTC-binding factor (Ctcf), DNA methy-
lation, DNA methyltranferase 1 (Dnmt1), epigenetics, poly(ADP-
ribosyl)ation (PARylation), poly(ADP-ribose) polymerase 1
(Parp1).
INTRODUCTION
PARylation [poly(ADP-ribosyl)ation] is a post-synthetic
modification catalysed by a family of enzymes known as PARP
[poly(ADP-ribose) polymerases] [1] and made reversible by the
activity of PARG [poly(ADP-ribose) glycohydrolase] [2]. This
post-synthetic modification introduces PARs [poly(ADP-ribose)
polymers] on to chromatin proteins and is peculiar since target
proteins can be modulated by two distinct mechanisms: covalent
and non-covalent PARylation [3–5]. It has been shown that fine
coordination of PARP/PARG activities represents an important
step in the modulation of gene expression [6–10]. In such a context
we have envisaged a mechanism whereby PARylation regulates
gene expression through its control of DNA methylation patterns
[11,12].
It has been suggested previously that misregulation of
PARylation may allow the introduction of anomalous methyl
groups on to some CGIs (CpG islands) [11–13]. In fact, it has
been found that Parp1 activity controls the unmethylated status
and expression of Dnmt1 [DNA (cytosine-5)-methyltransferase
1] [14], p16 [15] and thrombomodulin (THBD) genes [16],
whose altered expression is often characteristic of tumorigenic
patterns. We have proposed previously that PARs present on
PARylated Parp1, or on other transcription factors, are able to
bind to Dnmt1 non-covalently thus preventing enzyme access
to DNA and consequently DNA methylation [17]. Moreover,
we have demonstrated previously that cross-talk between Parp1
and Dnmt1 can be mediated by Ctcf (CCCTC-binding factor).
Ctcf promotes Parp1 automodification, accumulation of PARs
and ultimately the inhibition of Dnmt1 activity [18].
Ctcf binds CpG-rich sequences both in vitro and in vivo in a
methyl-sensitive fashion [19], and a role of Ctcf in protecting
unmethylated DNA regions located on both CGI and imprinting
control regions has been demonstrated [20–28]. The PARylated
form of Ctcf has been found involved with insulator function at
several Ctcf target sites [29]. Whether and how PARylation is
important for the maintaining of the unmethylated status of Ctcf
target sequences has not been sufficiently studied.
In the present study we focused on a well-characterized
unmethylated target site of Ctcf, showed that Ctcf associates
with PARylated Parp1 and Dnmt1 on this region, and that PARP
activity is required to preserve the DNA methylation profile. In
fact, depletion of PARs, obtained by PARG overexpression, causes
loss of binding of both Ctcf and Parp1 from DNA associated with
de novo methylation of Ctcf-bound CpGs. These observations
allow for the possibility that Ctcf plays a role in the PARP-
mediated protection of the unmethylated state of specific DNA
sequences.
MATERIALS AND METHODS
Cell culture
L929 mouse fibroblasts and A1 mouse embryonic fibroblasts
(from Parp1− / − mice) were maintained as sub-confluent
culture in high-glucose Dulbecco’s modified Eagle’s medium,
supplemented with 10% fetal bovine serum, 2 mM L-glutamine,
50 units/ml penicillin and 50 mg/ml streptomycin. All culture
solutions were from International PBI.
Abbreviations used: Ab, antibody; CGI, CpG island; ChIP, chromatin immunoprecipitation; Ctcf, CCCTC-binding factor; DMR1, differentially methylated
region 1; Dnmt1, DNA (cytosine-5)-methyltransferase 1; dsDNA, double-stranded DNA; DTT, dithiothreitol; H1, histone 1; H2B, histone 2B; IP,
immunoprecipitation; PARG, poly(ADP-ribose) glycohydrolase; Parp1, poly(ADP-ribose) polymerase 1; PARs, poly(ADP-ribose) polymers; PARylation,
poly(ADP-ribosyl)ation; RE-ChIP, sequential ChIP; TBST, Tris-buffered saline plus 0.05% Tween 20.
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Co-IP (immunoprecipitation)
Nuclei were collected from trypsinized and PBS-washed cells by
centrifugation (at 16000 g for 10 s at 4 ◦C) following incubation
(30 min) in isolation buffer [10 mM Hepes (pH 7.9), 10 mM KCl,
1.5 mM MgCl2, 50 mM NaF and 0.5 mM DTT (dithiothreitol)].
Nuclear fraction was lysed in RIPA buffer [50 mM Tris/HCl
(pH 8), 150 mM NaCl, 0.5% sodium deoxycholate, 0.1% SDS,
1%Nonidet P40 and 1mM EDTA), and protein concentration was
determined using the Bradford Protein Assay Reagent (Bio-Rad
Laboratories) with BSA (Promega) as the standard. Both buffers
were supplemented with protease inhibitors (Complete EDTA-
free, Roche Applied Science). Lysates (1.5 mg) were pre-cleared
with protein A (for IP anti-Ctcf and anti-Parp1) or G (for IP
anti-Dnmt1 and anti-PAR) agarose beads (Upstate Laboratories)
on a rotative shaker at 4 ◦C for 2.5 h. Pre-cleared lysates were
incubated with specific antibodies [rabbit polyclonal anti-Ctcf
Ab (antibody) (Upstate Laboratories), mouse monoclonal anti-
Dnmt1 Ab (Imgenex), rabbit polyclonal anti-Parp1 Ab (Alexis)
and mouse monoclonal anti-PAR Ab (Trevigen)] and with normal
rabbit or mouse IgG (Santa Cruz Biotechnology) on a rotative
shaker at 4 ◦C. The agarose beads, previously saturated with BSA
(1 μg/μl) overnight, were added to the lysate/Ab solutions and
incubated for 2 h on a rotative shaker at 4 ◦C. Subsequently,
beads were washed in IP buffer and boiled in SDS/PAGE sample
buffer. The eluted proteins were analyzed by SDS/PAGE (8%
gel) and Western blotting. The Abs used were: goat polyclonal
anti-Ctcf (Santa Cruz Biotechnology), mouse monoclonal anti-
Dnmt1 (Imgenex) and mouse monoclonal anti-Parp1 (C2-10,
Alexis Biochemicals).
In vitro protein-binding assay: pull down
ProBondTM resin (50 μl; Invitrogen) precharged with Ni2 +
was added to 1.2 ml of native purification buffer (Invitrogen) in
the presence or absence of 0.8 pmol of bvCTCF (baculovirus
recombinant Ctcf) recombinant His-tagged protein [18]. The mix
was incubated overnight on a rotative shaker at 4 ◦C. Then the resin
was collected and incubated with 0.4 pmol of human recombinant
PARP1 (Alexis) and/or 0.2 pmol of human recombinant DNMT1
(New England Biolabs) in 300 μl of native purification buffer
for 3 h on a rotative shaker at 4 ◦C. After washing the resin
with native purification buffer, proteins were eluted from the
beads by boiling in SDS/PAGE sample buffer. Protein–protein
interactions were analysed by SDS/PAGE (6% gel) and Western
blot analysis. The Abs employed were: rabbit polyclonal anti-
Ctcf (Upstate Laboratories), goat polyclonal anti-Ctcf (Santa Cruz
Biotechnology), mouse monoclonal anti-Dnmt1 (Imgenex) and
mouse monoclonal anti-Parp1 (C2-10, Alexis Biochemicals).
Polymer binding assay: polymer blot
Recombinant proteins (10–0.5 pmol) were dotted on to
nitrocellulose membranes (Hybond ECL Amersham Pharmacia
Biotech). The blots were treated as described previously [17].
Briefly, the blots were incubated in 5 ml of TBST {TBS [Tris-
buffered saline; 10 mM Tris and 0.15 M NaCl (pH 7.4)] plus
0.05% Tween 20} containing either PARylated Parp1 or ADP-
ribose polymers with/without dsDNA (double-stranded DNA)
of salmon sperm as competitor, at a PAR:dsDNA ratio of 1:25
(w/w). After incubation for 1 h at room temperature (21 ◦C), the
membranes were extensively washed with TBST and subjected
to immunostaining using mouse monoclonal anti-PAR Ab (10
HA, Trevigen) and goat anti-mouse horseradish peroxidase-
conjugated Abs (Santa Cruz Biotechnology). PARylated Parp1
and free PARs were obtained as described previously [17,18].
Recombinant H2B (histone 2B) and H1 (histone 1) (Sigma–
Aldrich) were used as positive controls for PARs binding, with
DNase I (Roche Applied Science) as the negative control.
ChIP (chromatin immunoprecipitation) and RE-ChIP
(sequential ChIP)
ChIP was performed as described previously [14] with the
following modifications. Starting sample consisted of 2×106
cross-linked cells. To obtain fragmented cross-linked chromatin
with an average fragment length of 750 bp, a sonication step was
performed consisting of about 30 pulses of 10 s each (with 10 s
rest between each) at 50% power in an ice bath (Labsonic M
sonifier, Braun Biotech international). Each washing step of ChIP
complexes was performed twice.
In RE-ChIP assays the primary ChIP (for Ctcf) was performed
accordingly to the standard protocol starting from 2×106 cells
for each IP. The ChIP complexes elution step was performed
in 100 μl of TE buffer [10mM Tris/HCl and 1mM EDTA
(pH 8)] containing 20 mM DTT by incubating the samples at
37 ◦C for 30 min. DTT was then removed using Microcon YM-
10 filters (Millipore) and the ChIP complexes were eluted in
100 μl of 1% SDS, 10 mM EDTA and 50 mM Tris/HCl (pH 8.0),
supplemented with protease inhibitors (complete EDTA-free,
Roche Applied Science). Samples were then diluted by adding
900 μl of IP dilution buffer [0.01% SDS, 1.1% Triton X-
100, 1.2 mM EDTA, 16.7 mM Tris/HCl (pH 8.0), 167 mM NaCl,
5 mg/ml BSA and protease inhibitors). An aliquot (10%)
of the sample was taken as the input. Secondary IPs (for
Parp1, Dnmt1 and PAR) were then performed according to
the standard ChIP protocol by adding the second Abs. Control
secondary IPs with purified normal rabbit total IgGs (Santa
Cruz Biotechnology) were also performed. Immunoprecipitated
DNA was resuspended in 50 μl of water and real-time PCR
amplifications were performed from 12 μl of the purified DNA.
Linearity of PCR amplifications was checked by making standard
curves generated using 1:1 serial dilutions (from 100 to 12.5%)
of the input. To exclude the presence of primer dimers or
PCR products from misannealed primers in the amplifications, a
melting curve was performed after each PCR run. PCR reactions
in the absence of template DNA were performed as a negative
control. The Abs used for IPs were: mouse monoclonal anti-PARs
(10 HA, Trevigen), rabbit polyclonal anti-Parp1 (Alexis), rabbit
polyclonal anti-Ctcf (Upstate Laboratories), rabbit polyclonal
anti-Dnmt1 (New England Biolabs) and normal rabbit IgGs (Santa
Cruz Biotechnology). Primers used for the amplification are
listed in the Supplementary Materials and methods section (at
http://www.BiochemJ.org/bj/441/bj4410645add.htm).
PARG overexpression
Transfection experiments were performed as described previously
[14]. For the ChIP assays 0.7×106 cells were seeded in
100×15 mm culture dishes and transfected with LipofectamineTM
Plus Reagent (Invitrogen) using the manufacturer’s protocol. The
assays were performed with 11 μg/dish of purified plasmid DNA
of either empty myc-vector (pCS2) as the control or a myc–
PARG construct (pCS2–Myc–PARG) together with 1.1 μg/dish
of pBabe-puro vector (Addgene) for puromycin selection of trans-
fected cells. After 24 h the cells were incubated for a further 24 or
72 h in culture medium supplemented with puromycin (2 μg/ml;
Calbiochem). Western blot assays of nuclear cell lysates were run
to prove transfection of myc-PARG. The Abs used were: mouse
monoclonal anti-Myc (9E10 clone, hybridoma-conditioned
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medium), mouse monoclonal anti-PAR (10 HA, Trevigen) and
rabbit polyclonal anti-Sp1 (H-225, Santa Cruz Biotechnology).
Genomic bisulfite sequencing
Genomic bisulfite sequencing analysis was performed as
described previously [14]. DMR1 amplicon was obtained by
nested PCR with the second PCR performed on 5 μl of the initial
amplification using the condition described by Lopes et al. [30].
The amplified DNAs were cloned into the TOPO TA-Cloning
Vector (pCR 2.1-TOPO kit, Invitrogen). Forty independent
bacterial clones for each sample were cultured in selective
LB (Luria–Bertani) medium and the corresponding recombinant
plasmids were extracted (PureLink Quick Plasmid Miniprep
Kit, Invitrogen) and sequenced. Sequencing was performed by
the Value Read sequencing service (Eurofins MWG Operon).
The primers and annealing temperatures are indicated in the
Supplementary Materials and methods section.
ChIP-CHOP assay
For ChIP-CHOP analysis of the DMR1 b and c fragments,
the Ctcf-, Parp1- and Dnmt-pulled down DNA (20 μl), and
input DNA (20 μl after 1:100 and 1:200 dilutions) from ChIP
assays were digested for 1 h at 37 ◦C with 10 units of either the
methylation-sensitive HpaII restriction enzyme or its methylation-
insensitive isoschizomer MspI (New England Biolabs). Digestion
was followed by heat inactivation. As a control, the IgG
ChIP fractions were also restricted. As an uncut control, ChIP
DNA fractions were prepared for HpaII digestion and immediately
heat inactivated to prevent restriction. Samples (2.5 μl) were than
subjected to PCR analysis with the same primers used in ChIP
assays. Amplification was performed using the Platinum PCR
SuperMix (Invitrogen) with 0.5 μM of the primers. PCR was run
for 40 (for input samples) or 45 (for ChIP DNA fractions) cycles
adopting the thermal conditions used for ChIP assays.
RESULTS
Dnmt1 is a new partner of Ctcf and is present in the Ctcf-PARylated
Parp1–Dnmt1 complex
The association between Parp1 and Ctcf, as well as the
interaction between Parp1 and Dnmt1, were reported previously
[17,18,31,32]. In the present paper we show by co-IP assay
that Ctcf, Dnmt1 and Parp1 form a complex in L929 mouse
fibroblasts nuclei (Figure 1a). Parp1 has been shown to interact
both with Ctcf and Dnmt1. To test the possibility that interactions
in the complex are mediated by Parp1, Ctcf–Dnmt1 co-IP assays
were performed on Parp1 knockout mouse fibroblasts (Parp1− / −
A1 cells). The results, shown in Figure 1(b), indicate that Ctcf
and Dnmt1 associate with each other even in the absence of
Parp1, thus excluding Parp1 as a mediator of interaction. Such
a conclusion was further corroborated by in vitro binding assays
between recombinant proteins. In fact, such experiments showed
that Ctcf directly binds both Parp1 and Dnmt1 and that the
ability of Ctcf to interact with Dnmt1 is not influenced by the
presence of Parp1 and vice versa that Parp1–Dnmt1 interaction
occurs independently of Ctcf (Figure 1c). Thus Dnmt1 adds to the
list of Ctcf protein partners [32,33], a finding that has not been
reported so far. Comparing the amount of each protein present in
the nuclear extract with the amount found in the co-IP, it appears
that most of cellular Dnmt1 is associated with Ctcf whereas only
a fraction of total Parp1 is engaged in such a complex (Figures 1a
and 1b).
Figure 1 Analysis of Ctcf interaction with Parp1 and Dnmt1
(a) Reciprocal co-IP of Ctcf, Parp1 and Dnmt1 in nuclear lysates. Non-specific rabbit IgGs were
used as negative control. (b) Immunoprecipitation of Ctcf in nuclear lysates from L929 (Parp1
proficient) and A1 (Parp1− / − ) cells. (c) Pull-down assay with recombinant brCtcf (His-tagged),
Parp1 and Dnmt1 proteins.
PAR interaction with Ctcf
The capability of the three proteins to be covalently and/or non-
covalently modified by PARylation was addressed by IP assays
performed using specific Abs against PARs (Figure 2a). The
results indicate that both Ctcf and Dnmt1 interact with polymers
or, at least, that they are complexed with other PARylated proteins.
Notably, the upward smear characterizing Parp1 immunostaining
(Figure 2a, middle panel) indicates that the auto-modified Parp1
(PARylated Parp1) can be immunoprecipitated by anti-PAR Abs.
Ctcf was reported to be covalently PARylated in vivo
[29,31,34]. In the present paper we show that the 130 kDa
Ctcf co-purifies with PARs (Figure 2a). Although this isoform
could be covalently modified by oligo(ADP-ribose) polymers
[31], the presence of a putative consensus sequence for non-
covalent PAR binding on the Ctcf protein [11] suggested that
non-covalent interactions might occur as well. In fact, we
found by in vitro polymer-binding assays that Ctcf does indeed
interact both with PARylated Parp1 and free PARs (Figure 2b
and Supplementary Figure S1 at http://www.BiochemJ.org/bj/
441/bj4410645add.htm). It is noteworthy that the affinity of PARs
for Ctcf is strikingly higher than that of H2B taken as positive
control [35] and that the interaction persists even in the presence
of competitor DNA [PARs:DNA ratio of 1:25 (w/w)]; the latter
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Figure 2 Analysis of Ctcf interaction with PARs
(a) Immunoprecipitation of PARs in nuclear lysates. Molecular mass is given in kDa on the left-hand side. (b) In vitro PAR binding assay with recombinant brCtcf. Blots were incubated with either in
vitro PARylated Parp1 (pParp1) or free PARs with or without competitor dsDNA. Non-covalent association between PARs and proteins was detected by anti-PAR Abs. Recombinant H2B and H1 were
used as positive control for PAR binding, whereas DNAse1 served as the negative control.
was used to rule out non-specific interactions due to the highly
negatively charged nature of PARs.
Co-localization of PARs, Parp1 and Dnmt1 with Ctcf on to Ctcf DNA
target sequences
We then asked whether the complex associates with well-known
DNA target sequences for Ctcf. By ChIP analysis we checked
the differentially methylated region located upstream of the Igf2
promoter 1 (DMR1) (Figure 3a) for occupancy by Ctcf, Parp1,
Dnmt1 and PARs.
Figure 3(B) clearly shows that Ctcf-specific DNA targets
within the DMR1 core region (fragments b and c) [23] are also
specifically occupied by Parp1 with its catalytic product (PARs)
and by Dnmt1. These fragments are significantly enriched in the
ChIP fractions if compared to the Actb promoter taken as negative
control.
The simultaneous presence of Parp1, PARs and Dnmt1 with
Ctcf on DMR1 region was further confirmed by RE-ChIP. A first
round ChIP, in which anti-Ctcf Abs were used, was followed
by RE-ChIP with anti-Parp1, anti-PARs or anti-Dnmt1 Abs. The
results show the presence of a Ctcf–Parp1–PARs–Dnmt1 complex
at the Ctcf consensus regions. No signal was detected in the
controls when anti-IgG Abs were used in the second round of
ChIP analysis (Figure 3c).
Depletion of PARs delocalizes the Ctcf–Parp1 complex from Ctcf
target sites
Depletion of PARs was obtained by overexpression of PARG. As
reported previously [14], the semistable overexpression of PARG
in L929 mouse fibroblasts led to a sharp decrease of endogenous
PARs (Figure 4a).
Co-IP carried out following PARG overexpression shows that
the Ctcf–Parp1–Dnmt1 complex is maintained in the nucleus
(Figure 4b). This indicates that PARs are not required for
the complex stability. We then asked if the presence of the
complex at the Ctcf DNA target sites was compromised after
the depletion of PARs. ChIP experiments show that DMR1 b
and c fragments co-purifying with PARs were notably reduced
after PARG overexpression with the associated loss of DNA
binding of both Ctcf and Parp1. By contrast, the overexpression
of PARG did not affect significantly the localization of Dnmt1
(Figure 4c).
Depletion of PARs leads to de novo methylation of Ctcf-bound CpGs
We have shown previously that inhibition of PAR synthesis leads
to de novo introduction of methyl groups on to DNA [14,36–
38]. These findings, and the well-known property of Ctcf to bind
selectively to unmethylated target sites, prompted us to test the
hypothesis that the displacement of Ctcf–Parp1 complex from
the DMR1 was associated with changes in the methylation pattern
of its DNA targets in PARs-depleted L929 cells.
We determined by bisulfite sequencing the methylation status
of CpGs within the DMR1 regions encompassing the Ctcf
target sequences assayed by ChIP experiments upon PARG
overexpression as shown in Figure 5.
Of great interest was the highly evident increase of methylation
detectable after PARG overexpression. In particular, CpGs
number 4, 5 and 6 underwent significant de novo methylation
with CpG 5 and 6 reaching full methylation. Notably, these CpGs
are the ones resident in the regions involved in the binding with
the Ctcf-PARylated Parp1–Dnmt1 complex, as shown by the ChIP
assays. This suggests that the loss of Ctcf binding upon PARG
overexpression is associated with DNA hypermethylation of Ctcf
target sequences.
The Ctcf-PARylated Parp1–Dnmt1 complex binds to unmethylated
DNA target sequences
Partial methylation of the Ctcf-binding targets within the DMR1
raised the question of whether the complex was preferentially
associated with the unmethylated DNA targets. To address this
issue, a methyl-sensitive ChIP-CHOP assay was performed for
the DMR1 b and c regions. DNA pulled-down with anti-Ctcf,
-Parp1 and -Dnmt1 Abs was digested with the isoschizomer
endonucleases HpaII and MspI. Both enzymes digest the sequence
CCGG containing CpG number 5 and 6 present in DMR1 b
and c respectively (see Figure 5), but HpaII is blocked by the
methylation of the CpG cytosine. The input DNA was digested
in parallel. The proportion of HpaII-sensitive DNA, present in
the input DNA and in the immunoprecipitated material, was
evaluated by end-point PCR (Figure 6). As expected, MspI
digestion destroyed the entire pool of DMR1 sequences, both in
the input samples and in the fractions of Ctcf, Parp1 and Dnmt1
ChIPs. Under the same conditions, HpaII digestion only partially
digested input DNA, which consists of both the methylated and
unmethylated DNA molecules. By contrast HpaII digestion of
ChIP fractions is undistinguishable from MspI digested DNA.
This indicates that in cells where the PARP activity was not
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Figure 3 ChIP analysis of DMR1 occupancy by Ctcf, Parp1, PARs and Dnmt1
(A) Schematic map of the locus. The DMR1 region is expanded to show the approximate position
of putative Ctcf-binding sites and of PCR primers used to detect the presence of specific DNA
sequences in ChIP complexes. Circles represent CpG dinuclotides. H, HpaII sites. (B) ChIP
analysis of DMR1 region carried out with anti-Ctcf, anti-Parp1, anti-Dnmt1 and anti-PAR Abs.
Beads alone (No Ab) and anti-IgG Abs were used as negative controls. Real-time PCR data are
expressed as percentage of the signal detected for the non-immunoprecipitated input (4 % of the
chromatin subjected to immunoprecipitation) taken as 100 %. The Actb promoter served as a
control. (C) Standard ChIP assay for Ctcf was followed by RE-ChIP to assess the co-occupancy
of Ctcf, with Parp1, PARs and Dnmt1 at the Ctcf DNA target sites within the DMR1. Real-time
PCR was performed for the DMR1 b and c fragments. The efficiency of RE-ChIP at each of the
sites was calculated as a percentage of the chromatin input that co-purified with Ctcf in the
first ChIP (10 % of the Ctcf ChIP fraction). Results are means +− S.E.M. calculated from three
experiments. *P < 0.05 compared with IgG controls (Student’s t test).
inhibited, Ctcf, Parp1 and Dnmt1 are predominantly bound to
DMR1 DNA fragments containing the unmethylated HpaII sites
(Figure 6).
DISCUSSION
Ctcf is a Zn-finger transcriptional factor involved in several
important biological roles [39], which range from the control
of imprinting to the onset of X chromosome inactivation [40–44].
Genome-wide studies have provided evidence that Ctcf, for which
thousands of binding sites scattered throughout the human and
mouse genomes have been found [45–47], also plays an important
role in the organization of chromatin architecture through
formation of intra-chromosomal loops or inter-chromosomal
bridges [48]. Ctcf uses these long-range interactions to mediate
gene expression/repression. Ctcf is considered an insulator protein
for its ability to bind insulator sequences which, according to the
way they regulate gene expression, are termed enhancer blocking
insulators or barrier insulators [40].
PARP activity has been shown previously to be essential for
mediating both enhancer blocking and barrier functions of Ctcf
[15,29,49]. In particular, Yu et al. [29] showed that the repressed
status of the maternal Igf2 allele was lost in cells treated with 3-
aminobenzamide, a general inhibitor of PAR polymerases. On the
other hand, it has been shown that Ctcf and Parp1 co-localize in
the vicinity of a DNA boundary region located 2 kbp upstream of
the p16 gene transcriptional start site preventing the spreading of
heterochromatin on to the promoter region. Interestingly, in cells
treated with 3-aminobenzamide, the promoter becomes repressed.
This indicates that PARP activity drives the boundary activity
of Ctcf at this locus. Furthermore, loss of Ctcf binding and
hypermethylation of p16 promoter CGI are associated in cancer
cells where p16 expression is silenced [15]. These results, together
with the fact that Parp1 localizes on Dnmt1 promoter protecting
its unmethylated state and expression by its activity [14], suggest
a role for PARylation in maintaining some regulatory CpG-rich
sequences in the unmethylated state.
The mechanism(s) by which Ctcf prevents the methylation
of specific CpG-rich DNA regions is unknown. However,
we demonstrated that Ctcf can bind Parp1 inducing its
automodification and that PARylated Parp1, in turn, inhibits
Dnmt1 activity through the polymers [17,18]. This evidence
prompted us to speculate that such a mechanism may underlie
the ability of Ctcf to maintain the proper methylation pattern of
its target binding sites.
At first, we searched for physical interaction between Parp1,
PARs, Dnmt1 and Ctcf. Co-IP and pull-down experiments
demonstrate a direct interaction between Ctcf, Dnmt1 and Parp1,
and provide information about the existence in vivo of a complex
between Ctcf-PARylated Parp1 and Dnmt1. Data of co-IP on
parp1− / − cells together with pull-down assays show that PARs
are not required for the complex formation between the three
proteins and that the interaction between Ctcf and Dnmt1
occurs independently of the presence of Parp1 in the complex.
Nonetheless, PARs, the catalytic product of PARP activity, take
part in the complex as shown by IP with anti-PAR Abs. In the
present paper we show that the 130 kDa Ctcf, co-purifies with
PARs. Although the130 kDa Ctcf was shown to be covalently
modified by oligo(ADP-ribose) polymers [31], the presence of a
putative consensus sequence for non-covalent PAR binding on the
Ctcf protein [11] suggested that a non-covalent interaction of Ctcf
with PARs might also occur. By polymer-blot analysis, the present
study demonstrates, for the first time, that Ctcf, besides being a
covalent acceptor of PARs [29,31], can also bind non-covalently
with PARs either free or Parp1-bound.
On the basis of the evidence of Ctcf interaction with Parp1,
PARs and Dnmt1, we determined whether these proteins
and PARs coexist at specific Ctcf DNA targets. The results of
the present study that DMR1, located upstream the Igf2 promoter
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Figure 4 Analysis of Ctcf–Parp1–Dnmt1 interactions and DMR1 region occupancy following PARG overexpression
(A) Western blot analysis of nuclear lysates from L929 cells overexpressing PARG after 24 and 72 h of puromycin selection. Analyses were performed by anti-PARs, anti-Myc Abs for exogenous
PARG and anti-Sp1 Ab as a control. (B) Immunoprecipitation of Ctcf in nuclear lysates from L929 cells overexpressing PARG 48 h after transfection. (C) ChIP analysis was carried out with anti-Ctcf,
anti-Parp1, anti-Dnmt1 and anti-PAR Abs in L929 cells overexpressing PARG compared with controls after 72 h of puromycin selection. Real-time PCR data are expressed as the percentage of the
signal detected for the non-immunoprecipitated input (4 % of the chromatin subjected to immunoprecipitation) taken as 100 %. Results are means +− S.E.M. for three experiments. The Actb promoter
was used as negative control. *P < 0.05 compared with controls (Student’s t test). Vector, L929 cells transfected with pCS2 empty vector; PARG, cells transfected with pCS2–Myc–PARG vector
containing full-length cDNA for human PARG.
1, required binding to Ctcf to maintain its methylation pattern
[23]. ChIP and RE-ChIP analyses of DMR1 sequence support the
proposition of co-occupancy by Ctcf, Parp1, PARs and Dnmt1.
These findings are consistent with previous reports showing co-
localization of Ctcf with Parp1 at the H19 DMR [31] and p16
promoter [15], and colocalization of Ctcf with both Parp1 and
Dnmt1 at the p53 promoter [50]. Ectopic PARG overexpression
in L929 cells allowed us to demonstrate that the Ctcf–Parp1
complex is released from Ctcf target sites in cells depleted of
PARs. In addition, the evidence that protein–protein interactions
between Ctcf, Parp1 and Dnmt1 are maintained in the nucleus
of cells depleted of PARs indicates that PARs are not required
for the complex stabilization, whereas they are necessary for the
localization of the complex at Ctcf target sites. All this suggests
that what is regulated by PARP activity is the ability of Ctcf to
bind its DNA target sites.
Since it is well known that the ability of Ctcf to bind its target
sites is methylation sensitive and that the inhibition of PARP
activity leads to CpG methylation, as a follow-up step we analysed
the DMR1 methylation pattern in PAR depleted and control L929
cells. It is noteworthy that the hypermethylation detected follow-
ing PAR depletion in DMR1 occurs only on those Ctcf consensus
regions on which the Ctcf–Parp1–PARs and Dnmt1 complex is
located. By contrast, the methylation level of other CpGs, residing
in DNA regions refractory to Ctcf binding in ChIP assays (i.e.
those contained in fragment a of DMR1), remains unchanged.
Preferential occupancy by Dnmt1 within Ctcf-positive target
sites supports the intriguing hypothesis of an instructive de novo
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Figure 5 Analysis of DNA methylation of DMR1 following PARG
overexpression
The methylation status of the DMR1 core region was evaluated by bisulfite sequencing in L929
cells overexpressing PARG compared with control cells after 72 h of puromycin selection.
Results are the mean frequency of methylation +− S.E.M. found for each CpG from three
independent PARG overexpression experiments. Vector, L929 cells transfected with pCS2 empty
vector; PARG, cells transfected with pCS2–Myc–PARG vector containing full-length cDNA for
human PARG. The open box in the map represents the approximate extent of the sequenced region
(H, HpaII sites). Grey boxes indicate the position of fragments assayed in ChIP experiments.
Figure 6 Ctcf, Parp1, and Dnmt1 bind to non-methylated DNA molecules
within the DMR1
Ctcf, Parp1, and Dnmt1 ChIPs were performed for the DMR1 b and c fragments. End-point PCR
was performed after digestion of ChIP fractions DNA and inputs with either HpaII (H, methylation
sensitive) or MspI (M, methylation insensitive) following heat inactivation of the restriction
enzymes. The input (4 % of the chromatin subjected to immunoprecipitation) was diluted 1/100
or 1/200 before restriction. The uncut (U) fractions consisted in HpaII digestions preventively
blocked by heat inactivation. W, PCR performed in the absence of added template.
methylation that may occur when PAR synthesis is antagonized
and affect the association of Ctcf with its target sequences; the
consequence of such events is the destabilization of the complex
in Ctcf target regions. The evidence that DMR1 CpG 5 is one
of the target sites responsible for the binding of methyl-sensitive
Ctcf [23], gives an intriguing rationale to the loss of binding of the
complex that we detected in these regions upon overexpression
of PARG. This possibility is strengthened by the finding that the
binding of Ctcf, Parp1, Dnmt1 and PARs within the DMR1 is
selective towards the DNA molecules containing unmethylated
CpGs, as indicated by ChIP-CHOP assays.
Globally, our results support a model envisaged in previous
reports [11] which proposed a mechanism of epigenetic control of
Ctcf boundary function based on PARylation. In this model, Ctcf
harbouring PARP activity at its DNA target sites prevents de novo
methylation of CpG dinucleotides by inhibiting Dnmt1 activity.
Thus defective PARP activity would cause hypermethylation of
Ctcf DNA targets through de-repression of Dnmt1.
A future aim is be to establish if PARylated Parp1, by itself
and/or following PARylation of Ctcf and/or other transcription
factors, may introduce an epigenetic code on chromatin, by
marking those DNA sequences that must be maintained in an
unmethylated state in normal cells and preventing Dnmt1 access
to these sequences.
Consistent with this, new interesting and emerging additional
findings are: (i) the identification of Dnmt1 among the protein
partners of Ctcf; (ii) the non-covalent binding between PARs and
Ctcf; (iii) the presence of Ctcf–Parp1–Dnmt1 complex, whose
stability is independent of PARP activity in the nucleus. The
complexity of the scenario where the players are Ctcf, Parp1 and
Dnmt1 goes in parallel with the complexity of Ctcf, which is
defined as multifunctional for the polyhedric roles in which it is
involved and for which thousands of target sites are present in the
genome [45–47].
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ADP-ribose polymers localized on Ctcf–Parp1–Dnmt1 complex prevent
methylation of Ctcf target sites
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Materials and Methods
ChIP and RE-ChIP
The following primers were used for the amplification in ChIP
and RE-ChIP assays: DMR1a, sense 5′-TGGCTCTTCAATG-
GACACCTT -3′ and antisense 5′-TCTCTGGAGAAGCCGCT-
GA -3′; DMR1b, sense 5′-TCCAGAATCGGGACTCTGTT -3′
and antisense 5′-CCTCTGCTAAGGGTCTCCTTT-3′; DMR1c,
sense 5′-TGGAATGAGGAACATCACCA-3′ and antisense 5′-
TCTATCCCTGGCTTTTCTGG-3′; and Actb, sense 5′-TTGGC-
TCCGCGTCGCTCACTCAC-3′ and antisense 5′-CCCCAGA-
ATGCAGGCCTAGTAACCGAGAC-3′.
Genomic bisulfite sequencing
The following primers and annealing temperatures were used
for the amplifications in the genomic bisulfite sequencing
experiments: DMR1, first sense 5′-GGTTAGGTGAAGGTTTT-
GTGGGTAGTTATA-3′ (annealing temperature = 50 ◦C) and
antisense 5′- ATATTCCCCTTTCAAATTCCAATCTACATC-
3′; and DMR1, second sense 5′-GGTGGTTTTTTAATGGATAT-
TTTAAGGTGA-3′ and antisense 5′-CCAACCTCTATCCC-
TAACTTTTCTAACCTC-3′ (annealing temperature = 52 ◦C).
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Figure S1 Analysis of Ctcf interaction with PARs
PAR-binding assays performed on different amounts of recombinant Ctcf protein. Blots were
incubated with either in vitro PARylated Parp1 (pParp1) (a) or free polymers (b). Non-covalent
association between PARs and proteins was detected by anti-PAR Abs. Equimolar amounts of
recombinant H2B and DNaseI were also assayed as positive and negative controls respectively.
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